相关实验视频
Updated: Jun 10, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.8K
在发作4·5小时内治疗急性中风的特内克与阿尔特相比 (ATTEST-2):一种随机,并行组,开放标签试验
Keith W Muir1, Gary A Ford2, Ian Ford3
1School of Cardiovascular & Metabolic Health, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK.
The Lancet. Neurology
|October 18, 2024
概括
在4.5小时内治疗急性缺血性中风时,tenecteplase与alteplase无差. 这项研究表明,由于易于施用,应优先选择基,支持其在中风血栓溶解中更广泛地采用.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔特普拉斯是急性缺血性中风的标准静脉血栓缓解剂.
- 丁氏甲提供了潜在的优势,包括单一玻尿酸的管理和可能更高的疗效.
- 该ATTEST-2试验旨在在中风发作后4.5小时内比较tenecteplase和alteplase.
研究的目的:
- 评估基在治疗急性缺血性中风方面是否与基相比不劣或优越.
- 为了评估与alteplase相比,tenecteplase的疗效和安全性.
- 提供证据证明在临床实践中更喜欢使用tenecteplase.
主要方法:
- 在39个英国中风中心进行了前性,随机化,并行组,开放标签试验,用掩盖的终点评估.
- 患有急性缺血性中风的成年人有资格在4.5小时内进行血栓溶解,被随机分为1:1接受阿尔特 (0.9毫克/千克) 或丁氏 (0.25毫克/千克).
- 主要终点是90天修改的兰金尺度 (mRS) 评分分布,使用顺序逻辑回归分析.
主要成果:
- 在90天的mRS分数分布方面,发现tenecteplase与alteplase不劣 (p<0.0001不劣).
- 甲没有表现出对高甲的优势 (p=0.43为优势).
- 安全结果,包括死亡率,症状性内出血和严重出血,在甲和高甲组之间是可比的.
结论:
- 在4.5小时内治疗急性缺血性中风时,tenecteplase 0.25 mg/kg与alteplase 0.9 mg/kg没有劣势.
- 较简单的注射 tenecteplase 使它成为一个首选的选择超过 alteplase 血栓溶解.
- 来自ATTEST-2的发现,以及其他试验,提供了强有力的证据,支持采用tenecteplase代替alteplase.
相关概念视频
Acute Coronary SyndromeI: Introduction
3
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Cardiopulmonary Resuscitation IV: Pharmacological Management
1
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1
Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Clot Retraction and Fibrinolysis
4.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.4K
Formation of the Platelet Plug
4.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K

